Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
N Biotechnol ; 60: 105-112, 2021 Jan 25.
Article in English | MEDLINE | ID: mdl-33045422

ABSTRACT

How would the European bio-based industrial landscape look now if the Bio-based Industries Joint Undertaking (BBI JU) had not been created? While we obviously cannot know this, today after almost seven years of operation following its creation in 2014, the BBI JU has certainly established a solid reputation for high impact delivery and is driving the systemic transformation of the EU bio-based sector. This article provides an overview of the most visible effects generated in the bio-based sector together with the principal achievements realised so far (2014-2019), using practical examples from BBI JU projects. The partnership is on track to out-perform almost all of its performance targets by the end of 2020, including the production of new bio-based materials and the creation of new value chains, and has launched nine flagship projects that see biorefineries operating at pre-commercial scale, the first of their kind in Europe. The main reasons behind the success of the initiative, including the added value of working as an institutionalised partnership, are discussed. Several factors are highlighted, including the dynamic alignment of the strategies of both the EU and industry, and the efficiency of the programming process, which is driven by the industry in close collaboration with the European Commission. Finally, the article discusses the relevance of the work already done with a view to a future initiative under Horizon Europe, in the context of the European Green Deal and the needs of future generations.


Subject(s)
Biotechnology , Drug Industry , Pharmaceutical Preparations/chemistry , Public-Private Sector Partnerships , Europe
2.
Front Bioeng Biotechnol ; 8: 619066, 2020.
Article in English | MEDLINE | ID: mdl-33553123

ABSTRACT

This paper gives an overview of development of the EU-bioeconomy, 2014-2020. The Vision of the new Circular Bio-based Economy, CBE is presented: Unlocking the full potential of all types of sustainably sourced biomass, crop residues, industrial side-streams, and wastes by transforming it into value-added products. The resulting product portfolio consists of a wide spectrum of value-added products, addressing societal and consumer needs. Food and feed, bio-based chemicals, materials, health-promoting products; and bio-based fuels. The pillars of CBE are described, including biotechnology, microbial production, enzyme technology, green chemistry, integrated physical/chemical processing, policies, conducive framework conditions and public private partnerships. Drivers of CBE are analyzed: Biomass supply, biorefineries, value chain clusters, rural development, farmers, foresters and mariners; urgent need for climate change mitigation and adaptation, and stopping biodiversity loss. Improved framework conditions can be drivers but also obstacles if not updated to the era of circularity. Key figures, across the entire BBI-JU project portfolio (2014-2020) are provided, including expansion into biomass feedstocks, terrestrial and aquatic, and an impressive broadening of bio-based product portfolio, including higher-value, health-promoting products for man, animal, plants and soil. Parallel to this, diversification of industrial segments and types of funding instruments developed, reflecting industrial needs and academic research involvement. Impact assessment is highlighted. A number of specific recommendations are given; e.g., including international win/win CBE-collaborations, as e.g., expanding African EU collaboration into CBE. In contrast to fossil resources biological resources are found worldwide. In its outset, circular bio-based economy, can be implemented all over, in a just manner, not the least stimulating rural development.

3.
N Biotechnol ; 40(Pt A): 31-39, 2018 Jan 25.
Article in English | MEDLINE | ID: mdl-28666809

ABSTRACT

This article discusses the preparation, structure and objectives of the Bio-based Industries Joint Undertaking (BBI JU). BBI JU is a public-private partnership (PPP) between the European Commission (EC) and the Bio-based Industries Consortium (BIC), the industry-led private not-for-profit organisation representing the private sectors across the bio-based industries. The model of the public-private partnership has been successful as a new approach to supporting research and innovation and de-risking investment in Europe. The BBI JU became a reality in 2014 and represents the largest industrial and economic cooperation endeavour financially ever undertaken in Europe in the area of industrial biotechnologies. It is considered to be one of the most forward-looking initiatives under Horizon 2020 and demonstrates the circular economy in action. The BBI JU will be the catalyst for this strategy to mobilise actors across Europe including large industry, small and medium-sized enterprises (SMEs), all types of research organisations, networks and universities. It will support regions and in doing so, the European Union Member States and associated countries in the implementation of their bioeconomy strategies.


Subject(s)
Biotechnology , Conservation of Natural Resources , Economic Development , Europe , Models, Economic , Public-Private Sector Partnerships
SELECTION OF CITATIONS
SEARCH DETAIL
...